Expression of the human apoE2 isoform in adipocytes: Altered cellular processing and impaired adipocyte lipogenesis

Journal of Lipid Research

Volumn 52, Issue 9, 2011, Pages 1733-1741

  Huang, Zhi H ^a   Maeda, Nobuyo ^b   Mazzone, Theodore ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adipogenesis; Adipose tissue; Apolipoprotein; Fatty acid; Obesity

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E2 DERIVATIVE; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; APOE GENE; ARTICLE; CELL CULTURE; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE; GENE CONTROL; GENE EXPRESSION; GONADAL FAT PAD; HYPERLIPIDEMIA; INTERNALIZATION; KNOCKOUT GENE; LIPID HYDROLYSIS; LIPID METABOLISM; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; TISSUE CULTURE;

ADIPOCYTES; ANIMALS; APOLIPOPROTEIN E2; CELLS, CULTURED; FATTY ACIDS; GENE KNOCK-IN TECHNIQUES; HUMANS; LIPOGENESIS; LIPOPROTEINS, VLDL; MICE; MICE, INBRED C57BL; PROTEIN ISOFORMS; TISSUE CULTURE TECHNIQUES;

EID: 80051825018     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M017160     Document Type: Article

References (37)

1. Ford, E S, and A H Mokdad. 2008. Epidemiology of obesity in the Western Hemisphere. J. Clin. Endocrinol. Metab. 93: S1-S8.
2. Despres, J P, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O F Bertrand, and P. Poirier. 2008. Abdominal obesity and the metabolic syndrome: Contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 28: 1039-1049.
3. Canoy, D., S M Boekholdt, N. Wareham, R. Luben, A. Welch, S. Bingham, I. Buchan, N. Day, and K T Khaw. 2007. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: A population-based prospective study. Circulation. 116: 2933-2943. (Pubitemid 350291200)
4. Huang, Z H, C A Reardon, and T. Mazzone. 2006. Endogenous apoE expression modulates adipocyte triglyceride content and turnover. Diabetes. 55: 3394-3402. (Pubitemid 44923598)
5. Huang, Z H, D. Gu, and T. Mazzone. 2009. Role of adipocyte-derived apoE for modulating adipocyte size, lipid metabolism, and gene expression in vivo. Am. J. Physiol. Endocrinol. Metab. 296: E1110-E1119.
6. Huang, Z H, R D Minshall, and T. Mazzone. 2009. Mechanism for endogenously expressed APOE modulation of adipocyte VLDL metabolism: Role in endocytic and lipase-mediated metabolic pathways. J. Biol. Chem. 284: 31512-31522.
7. Yue, L, and T. Mazzone. 2011. Endogenous adipocyte apolipoprotein E is colocalized with caveolin at the adipocyte plasma membrane. J. Lipid Res. 52: 489-498.
8. Yue, L., N. Rassouli, G. Ranganathan, P A Kern, and T. Mazzone. 2004. Divergent effects of PPARγ agonists and TNFα on adipocyte apoE expression. J. Biol. Chem. 279: 47626-47632.
9. Huang, Z H, R M Luque, R D Kineman, and T. Mazzone. 2007. Nutritional regulation of adipose tissue apolipoprotein E expression. Am. J. Physiol. Endocrinol. Metab. 293: E203-E209. (Pubitemid 47105933)
10. Rao, P., Z H Huang, and T. Mazzone. 2007. Angiotensin II regulates adipocyte apolipoprotein E expression. J. Clin. Endocrinol. Metab. 92: 4366-4372. (Pubitemid 350074758)
11. Yue, L., J W Christman, and T. Mazzone. 2008. Tumor necrosis factor-alpha-mediated suppression of adipocyte apolipoprotein E gene transcription: Primary role for the nuclear factor (NF)-kappaB pathway and NFkappaB p50. Endocrinology. 149: 4051-4058.
12. Espiritu, D J, and T. Mazzone. 2008. Oxidative stress regulates adipocyte apolipoprotein E and suppresses its expression in obesity. Diabetes. 57: 2992-2998.
13. Yue, L, and T. Mazzone. 2009. Peroxisome proliferator-activated receptor {gamma} stimulation of adipocyte ApoE gene transcription mediated by the liver receptor X pathway. J. Biol. Chem. 284: 10453-10461.
14. Espiritu, D J, Z H Huang, Y. Zhao, and T. Mazzone. 2010. Hyperglycemia and advanced glycosylation end products suppress adipocyte apoE expression: Implications for adipocyte triglyceride metabolism. Am. J. Physiol. Endocrinol. Metab. 299: E615-E623.
15. Huang, Y. 2010. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases. Curr. Opin. Lipidol. 21: 337-345.
16. Sima, A., A. Iordan, and C. Stancu. 2007. Apolipoprotein E polymorphism - a risk factor for metabolic syndrome. Clin. Chem. Lab. Med. 45: 1149-1153. (Pubitemid 47396270)
17. Araki, S., D K Moczulski, L. Hanna, L J Scott, J H Warram, and A S Krolewski. 2000. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: Results of case-control and family-based studies. Diabetes. 49: 2190-2195.
18. Srinivasan, S R, C. Ehnholm, A. Elkasabany, and G S Berenson. 2001. Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study. Metabolism. 50: 696-702. (Pubitemid 32551824)
19. Carvalho-Wells, A L, K G Jackson, R. Gill, E. Olano-Martin, J A Lovegrove, C M Williams, and A M Minihane. 2010. Interactions between age and apoE genotype on fasting and postprandial triglycerides Levels. Atherosclerosis. 212: 481-487.
20. Hara, M., T. Matsushima, H. Satoh, N. Iso-o, H. Noto, M. Togo, S. Kimura, Y. Hashimoto, and K. Tsukamoto. 2003. Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans. Arterioscler. Thromb. Vasc. Biol. 23: 269-274. (Pubitemid 36231939)
21. Fan, D., S. Qiu, C D Overton, P G Yancey, L L Swift, W G Jerome, M F Linton, and S. Fazio. 2007. Impaired secretion of apolipoprotein E2 from macrophages. J. Biol. Chem. 282: 13746-13753. (Pubitemid 47100531)
22. Cullen, P., A. Cignarella, B. Brennhausen, S. Mohr, G. Assmann, and A. Von Eckardstein. 1998. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J. Clin. Invest. 101: 1670-1677. (Pubitemid 28198496)
23. Yoshida, H., A H Hasty, A S Major, H. Ishiguro, Y R Su, L A Gleaves, V R Babaev, M F Linton, and S. Fazio. 2001. Isoformspecific effects of apolipoprotein E on atherogenesis: Gene transduction studies in mice. Circulation. 104: 2820-2825. (Pubitemid 33126657)
24. Gong, J S, M. Kobayashi, H. Hayashi, K. Zou, N. Sawamura, S C Fujita, K. Yanagisawa, and M. Michikawa. 2002. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J. Biol. Chem. 277: 29919-29926.
25. Ji, Z S, R D Miranda, Y M Newhouse, K H Weisgraber, Y. Huang, and R W Mahley. 2002. Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. J. Biol. Chem. 277: 21821-21828.
26. Zhong, N., G. Ramaswamy, and K H Weisgraber. 2009. Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function. J. Biol. Chem. 284: 27273-27280.
27. Arbones-Mainar, J M, L A Johnson, M K Altenburg, and N. Maeda. 2008. Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. Int. J. Obes. (Lond). 32: 1595-1605.
28. Arbones-Mainar, J M, L A Johnson, M K Altenburg, H S Kim, and N. Maeda. 2010. Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4. FASEB J. 24: 3809-3818.
29. Malloy, S I, M K Altenburg, C. Knouff, L. Lanningham-Foster, J S Parks, and N. Maeda. 2004. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. Arterioscler. Thromb. Vasc. Biol. 24: 91-97. (Pubitemid 38082417)
30. Knouff, C., M E Hinsdale, H. Mezdour, M K Altenburg, M. Watanabe, S H Quarfordt, P M Sullivan, and N. Maeda. 1999. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Invest. 103: 1579-1586.
31. Sullivan, P M, H. Mezdour, S H Quarfordt, and N. Maeda. 1998. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J. Clin. Invest. 102: 130-135. (Pubitemid 28323839)
32. Sullivan, P M, H. Mezdour, Y. Aratani, C. Knouff, J. Najib, R L Reddick, S H Quarfordt, and N. Maeda. 1997. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272: 17972-17980. (Pubitemid 27306374)
33. Knouff, C., O. Briand, S. Lestavel, V. Clavey, M. Altenburg, and N. Maeda. 2004. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor. Biochim. Biophys. Acta. 1684: 8-17. (Pubitemid 39140864)
34. Huang, Z H, D. Gu, and T. Mazzone. 2004. Oleic acid modulates the post-translational glycosylation of macrophage apoE to increase its secretion. J. Biol. Chem. 279: 29195-29201. (Pubitemid 38915793)
35. Mazzone, T., L. Pustelnikas, and C A Reardon. 1992. Post-translational regulation of macrophage apoprotein E production. J. Biol. Chem. 267: 1081-1087.
36. Clavel, C., A. Durlach, V. Durlach, and P. Birembaut. 1995. Rapid and safe determination of human apolipoprotein E genotypes by miniaturised SDS-PAGE in non-insulin dependent diabetes mellitus. J. Clin. Pathol. 48: 295-299.
37. Hixson, J E, and D T Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548. (Pubitemid 20107994)